The global psoriatic arthritis (PsA) market continues to grow as healthcare providers adopt advanced therapeutics to manage psoriatic arthritis, a chronic autoimmune condition affecting joints, tendons and skin. PsA is closely associated with psoriasis and can lead to progressive joint damage, reduced mobility, pain and long-term disability if untreated. With rising disease awareness...